Profile data is unavailable for this security.
About the company
Bactiguard Holding AB is a Sweden-based company engaged in the development of solutions for preventing of device-related healthcare associated infections (HAI). Its technology is based on the Bactiguard Infection Protection (BIP), a thin coating permanently bound to the surface of medical devices. It consists of the noble metals: gold, palladium and silver, which reduces the adhesion of bacteria to the coated surfaces. Its product portfolio includes: BIP Foley Catherer, made from medical grade latex, and BIP Foley Catheter - Silicone, used for drainage and irrigation of the bladder; BIP Endotracheal Tube, for general anesthesia, intensive care, and emergency medicine for airway management and mechanical ventilation; and BIP Central Venous Catherer, made of polyurethane and used to administer drugs and intravenous solutions, monitor pressure and blood sampling. The Company is also present in Portugal, via a distribution agreement with Socime Medical Ltd, and Zambia.
- Revenue in SEK (TTM)220.81m
- Net income in SEK-126.19m
- Incorporated2010
- Employees191.00
- LocationBactiguard Holding ABBiblioteksgatan 25STOCKHOLM 114 35SwedenSWE
- Phone+46 84405880
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C Rad AB | 424.62m | 35.43m | 1.24bn | 87.00 | 36.00 | 4.71 | 27.89 | 2.93 | 1.05 | 1.05 | 12.57 | 8.03 | 1.14 | 4.42 | 3.82 | 4,880,632.00 | 9.60 | 5.09 | 13.75 | 7.02 | 45.83 | 43.12 | 8.41 | 4.86 | 2.27 | 139.13 | 0.0064 | 0.00 | 40.92 | 17.44 | 375.05 | 10.89 | 33.69 | -- |
| ADDvise Group AB (publ) | 1.48bn | 110.80m | 1.47bn | 620.00 | 23.45 | 3.28 | 6.57 | 0.9986 | 0.5864 | 0.5864 | 7.84 | 4.20 | 0.5506 | 6.73 | 5.52 | 2,365,224.00 | 4.14 | 3.72 | 5.17 | 4.77 | 47.63 | 48.95 | 7.51 | 5.89 | 1.09 | 2.99 | 0.6608 | 0.9405 | 44.30 | 38.62 | 27.62 | -- | 30.35 | -- |
| Stille AB | 294.89m | 26.65m | 1.83bn | 106.00 | 38.41 | 1.62 | 44.70 | 6.22 | 5.31 | 5.31 | 58.76 | 126.11 | 0.514 | -- | -- | 2,782,019.00 | 4.64 | 7.03 | 5.21 | 8.19 | 44.82 | 43.93 | 9.04 | 9.85 | 6.54 | 3.36 | 0.00 | 21.98 | 19.70 | 16.78 | -2.48 | 5.34 | 23.62 | -- |
| Bactiguard Holding AB | 220.81m | -126.19m | 2.24bn | 191.00 | -- | 7.35 | -- | 10.12 | -3.60 | -3.60 | 6.30 | 9.80 | 0.3035 | 4.28 | 6.00 | 1,017,544.00 | -17.35 | -7.56 | -19.82 | -8.81 | 29.87 | 47.91 | -57.15 | -26.28 | 1.64 | -11.90 | 0.4129 | -- | -11.96 | 6.46 | -161.71 | -- | 8.43 | -- |
| Sedana Medical AB (publ) | 164.91m | -22.83m | 2.25bn | 83.00 | -- | 2.28 | 33,161.02 | 13.67 | -0.2299 | -0.2299 | 1.66 | 9.95 | 0.1564 | 1.24 | 8.10 | 2,087,443.00 | -2.17 | -5.77 | -2.28 | -6.08 | 70.50 | 64.06 | -13.85 | -36.13 | 7.38 | -- | 0.0043 | -- | 25.23 | 21.59 | 18.90 | -- | 42.12 | -- |
| Detection Technology Oyj | -1.16tn | -1.16tn | 2.69bn | 478.00 | -- | 3.17 | -- | -- | -- | -- | -- | 4.97 | -- | -- | -- | -- | -- | 9.34 | -- | 11.96 | -- | 47.44 | -- | 8.22 | 3.13 | -- | 0.081 | 53.45 | 5.29 | 2.02 | 7.55 | -18.03 | -14.88 | -9.55 |
| BICO Group AB | 2.25bn | -1.70bn | 3.20bn | 884.00 | -- | 0.6701 | -- | 1.42 | -23.61 | -27.66 | 31.60 | 69.18 | 0.2487 | 2.24 | 3.06 | 2,545,136.00 | -18.77 | -- | -20.89 | -- | 52.34 | -- | -75.47 | -- | 1.91 | -1.05 | 0.2852 | -- | 6.09 | -- | -1,889.33 | -- | -- | -- |
| Medistim ASA | 527.95m | 101.97m | 3.22bn | 152.00 | 31.50 | 7.52 | 25.53 | 6.10 | 5.60 | 5.60 | 29.01 | 23.48 | 1.03 | 0.7765 | 6.15 | 3,492,704.00 | 19.95 | 22.93 | 24.07 | 28.52 | 79.02 | 78.25 | 19.31 | 20.64 | 2.99 | -- | 0.0206 | 75.25 | 7.00 | 10.06 | -8.91 | 12.72 | 0.033 | 14.87 |
| Holder | Shares | % Held |
|---|---|---|
| Nordea Investment Management ABas of 31 Jul 2023 | 3.42m | 11.02% |
| Fj�rde AP-fondenas of 31 Jul 2023 | 3.37m | 10.86% |
| Handelsbanken Fonder ABas of 31 Mar 2024 | 2.29m | 7.38% |
| SEB Investment Management ABas of 25 Mar 2024 | 1.88m | 6.04% |
| AMF Fonder ABas of 31 Jul 2023 | 1.71m | 5.50% |
| Lancelot Asset Management ABas of 30 Jun 2020 | 650.00k | 2.09% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 30 Dec 2022 | 303.16k | 0.98% |
| Skandia Investment Management ABas of 29 Feb 2024 | 65.21k | 0.21% |
| Deka Investment GmbHas of 30 Sep 2023 | 24.00k | 0.08% |
| Storebrand Asset Management ASas of 31 Jan 2024 | 23.44k | 0.08% |
